AVADEL PHARMACEUTICALS PLC — Director's Dealing 2024

Dec 11, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2024-12-10

Reporting Person: Glass Geoffrey Michael (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-10	Ordinary Shares	P	10075	$9.89	Acquired	69075	Indirect
2024-12-10	Ordinary Shares	P	10204	$9.8	Acquired	75904	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	11000	Direct

Footnotes

F1: These Ordinary Shares are held by The Geoffrey Glass Trust of which the Reporting Person is a co-trustee. The Reporting Person is the sole beneficiary of the trust.

F2: These Ordinary Shares are held by Geoffrey M. Glass Revocable Trust U/T/D August 26, 2020 of which the Reporting Person is trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust.